Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology

Among the most challenging of clinical targets for cancer immunotherapy are Tumor Associated Carbohydrate Antigens (TACAs). To augment immune responses to TACA we are developing carbohydrate mimetic peptides (CMPs) that are sufficiently potent to activate broad-spectrum anti-tumor reactivity. Howeve...

Full description

Bibliographic Details
Main Authors: Thomas Kieber-Emmons, Anastas Pashov, Behjatolah Monzavi-Karbassi, Fariba Jousheghany, Cecile Artaud, Leah Hennings
Format: Article
Language:English
Published: MDPI AG 2011-11-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/3/4/4151/